- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
COVID-19 Vaccine: Zydus Cadila, Bharat Biotech in Phase II trial
![COVID-19 Vaccine: Zydus Cadila, Bharat Biotech in Phase II trial COVID-19 Vaccine: Zydus Cadila, Bharat Biotech in Phase II trial](https://medicaldialogues.in/h-upload/2020/09/04/750x450_133995-clinical-trial2.webp)
New Delhi: Indian Council of Medical Research (ICMR) Director General Balaram Bhargava said on Tuesday that Bharat Biotech and Zydus Cadilla are doing human trials of the second phase of the Corona vaccine while Serum Institute of India is about to start the third phase of testing soon.
Speaking at a press conference organised by the Union Ministry of Health and Family, Dr Bhargava said at present there are three Corona vaccines in various stages of clinical trials. He said Phase I human trials of Cadila's Corona vaccine has been completed and volunteers have been selected for Phase II testing.
There are three doses of this vaccine which are to be taken at intervals of 28–28 days.
The first phase of Bharat Biotech has also been completed and the results are being reviewed. Bharat Biotech has also selected the volunteers for the Phase II trial.
The Serum Institute tested on 100 volunteers for a second phase test for the Corona vaccine and then took a seven-day break as they wanted to begin the third phase. The Serum Institute intends to conduct a Phase III trial on 1,500 patients at 14 sites across the country.
bharat biotechbharat biotech newsicmrbalaram bhargavazydus cadilazydus cadila newscoronavirus vaccinecovid-19
Source : UNIRuchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story